- Citations, last 5 years
- 23
- Works, last 5 years
- 6
- h-index
- 17
- Scientists listed
- 1
- Grants since 2016
- 100
Grants received
2021–2022 · grant · Standard Grant
SBIR Phase I: A simple, targeted and flexible method for transferring value-added genes from wild relatives of crop plants
Kanwardeep Rawale · 490 BioTech (United States) · funded by National Science Foundation
2021–2023 · research · R41
Evaluation of stability and safety of platelet-like particles for treating bleeding after trauma
Seema Nandi · 490 BioTech (United States) · funded by National Institutes of Health
2021–2023 · research · R43
Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2021–2026 · research · R42
2-HOBA for Treatment of Pulmonary Hypertension
John A Rathmacher · 490 BioTech (United States) · funded by National Institutes of Health
2021–2022 · research · R41
2-HOBA for Treatment of Pulmonary Hypertension
John A Rathmacher · 490 BioTech (United States) · funded by National Institutes of Health
2021–2027 · research · R44
Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2021–2026 · research · R42
2-HOBA for Treatment of Pulmonary Hypertension
John A Rathmacher · 490 BioTech (United States) · funded by National Institutes of Health
2021–2027 · research · R42
Development of a radiation-activatable nanoparticle for lung cancer therapy
Jin Xie · 490 BioTech (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of safe and effective immunotherapeutics for treatment of opioid abuse and overdose
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2020–2021 · research · R43
Intensified, High-Rate Reductive Immobilization of Hexavalent Chromium
Fatemeh Shirazi · 490 BioTech (United States) · funded by National Institutes of Health
2020–2023 · research · R43
Plasmonic Glycan Arrays for Highly Sensitive Detection of Glycan-binding Proteins
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2020–2023 · research · R43
Establishment of human mini-Testis for reproductive toxicity testing
Lei Yin · 490 BioTech (United States) · funded by National Institutes of Health
2019–2024 · research · R44
Bioinformatic Tools for Interpretation of Glycan Array Data
Brian B. Haab · 490 BioTech (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Bioinformatic Tools for Interpretation of Glycan Array Data
Brian B. Haab · 490 BioTech (United States) · funded by National Institutes of Health
2019–2024 · research · R44
Bioinformatic Tools for Interpretation of Glycan Array Data
Brian B. Haab · 490 BioTech (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Bioinformatic Tools for Interpretation of Glycan Array Data
Brian B. Haab · 490 BioTech (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Developing high-affinity nanobodies to tumor-associated glycan antigens
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2018–2023 · research · R42
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis
Kailash C Chadha · 490 BioTech (United States) · funded by National Institutes of Health
2018–2020 · research · R43
A method to determine mRNA isoform frequencies using novel primer generators
John T Welsh · 490 BioTech (United States) · funded by National Institutes of Health
2018–2025 · research · R42
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis
Kailash C Chadha · 490 BioTech (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Selective Inhibition of Platelet GPIb-alpha Binding to Leukocyte Mac-1 as a Therapeutic for Multiple Sclerosis
David Chess · 490 BioTech (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging
Gary S Sayler · 490 BioTech (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Development of a Percutaneous Pulmonary Artery Drainage Device to Unload LV During VA ECMO Support for Severe Cardiogenic Shock
Stephen R Topaz · 490 BioTech (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
IGF::OT::IGF VITA 2 - DEVELOPING AN ANTI-THROMBOTIC MONOCLONAL ANTIBODY (MAB) WITH IMPROVED SAFETY AND EFFICACY
Glen Gaughan · 490 BioTech (United States) · funded by National Institutes of Health
2018–2020 · research · R42
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis
Kailash C Chadha · 490 BioTech (United States) · funded by National Institutes of Health
2018–2023 · research · R42
KAPS Biotech: A novel biomarker to improve prostate cancer diagnosis
Kailash C Chadha · 490 BioTech (United States) · funded by National Institutes of Health
2017–2018 · research · R43
High sensitive and specific, Point-of-use lateral flow strip for on-site test of cannabis intoxication
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2017–2025 · cooperative agreement · U44
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2020 · research · R42
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2019 · research · R43
A Comprehensive 5K plus Glycan Microarray
Jian Zhang · 490 BioTech (United States) · funded by National Institutes of Health
2017–2025 · research · R44
A Comprehensive 5K Plus Glycan Microarray
Lei Li · 490 BioTech (United States) · funded by National Institutes of Health
2017–2025 · cooperative agreement · U44
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2024 · research · R44
A Comprehensive 5K Plus Glycan Microarray
Lei Li · 490 BioTech (United States) · funded by National Institutes of Health
2017–2018 · contract · N43
IGF::OT::IGF Single domain antibodies for detection and imaging of modified RNA nucleosides
Xichun Zhou · 490 BioTech (United States) · funded by National Institutes of Health
2017–2018 · research · R41
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2025 · cooperative agreement · U44
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2020 · research · R43
A Comprehensive 5K plus Glycan Microarray
Jian Zhang · 490 BioTech (United States) · funded by National Institutes of Health
2017–2021 · research · R42
Development of a protein drug for pancreatic cancer treatment
Zhi-Ren Liu · 490 BioTech (United States) · funded by National Institutes of Health
2017–2024 · research · R44
A Comprehensive 5K Plus Glycan Microarray
Lei Li · 490 BioTech (United States) · funded by National Institutes of Health
2016–2017 · research · R41
A chimeric protein for the selective expansion of regulatory T cells
Bellur S Prabhakar · 490 BioTech (United States) · funded by National Institutes of Health